A New Mode of Cytotoxic T Lymphocyte Induction Secondary to Alteration of the Peptide/Major Histocompatibility Complex Class I Repertoire by Antigen Processing Defects

  • Takayuki KanasekiEmail author
  • Yosuke Shionoya
  • Noriyuki Sato


The cell surface repertoire of peptide/major histocompatibility complex (MHC) class I (pMHCI) provides potential ligands for circulating CD8+ cytotoxic T lymphocytes (CTLs). Because the action of antigen-processing machineries inside cells are necessary for optimizing pMHCI formation, it has been believed that antigen-processing defect (APD) attenuates any CTL responses. However, recent evidences demonstrate that the cells with APD often present a unique pMHCI repertoire harboring immunogenic peptides that are never displayed on normal cells. Here we focus on the absence of endoplasmic reticulum (ER)-resident editors ERAAP or tapasin and discuss a new mode of CTL induction secondary to it.


MHC class I Antigen processing ERAAP Tapasin 


  1. Atkins D, Breuckmann A, Schmahl GE, Binner P, Ferrone S, Krummenauer F, Storkel S, Seliger B (2004) MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma. Int J Cancer 109(2):265–273Google Scholar
  2. Belicha-Villanueva A, Golding M, McEvoy S, Sarvaiya N, Cresswell P, Gollnick SO, Bangia N (2010) Identification of an alternate splice form of tapasin in human melanoma. Hum Immunol 71(10):1018–1026. doi: 10.1016/j.humimm.2010.05.019
  3. Blanchard N, Kanaseki T, Escobar H, Delebecque F, Nagarajan NA, Reyes-Vargas E, Crockett DK, Raulet DH, Delgado JC, Shastri N (2010) Endoplasmic reticulum aminopeptidase associated with antigen processing defines the composition and structure of MHC class I peptide repertoire in normal and virus-infected cells. J Immunol 184(6):3033–3042. doi: 10.4049/jimmunol.0903712 CrossRefPubMedCentralPubMedGoogle Scholar
  4. Braud VM, Allan DS, O’Callaghan CA, Soderstrom K, D’Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ (1998) HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391(6669):795–799. doi: 10.1038/35869 CrossRefPubMedGoogle Scholar
  5. Cresswell P, Bangia N, Dick T, Diedrich G (1999) The nature of the MHC class I peptide loading complex. Immunol Rev 172:21–28CrossRefPubMedGoogle Scholar
  6. Dong G, Wearsch PA, Peaper DR, Cresswell P, Reinisch KM (2009) Insights into MHC class I peptide loading from the structure of the tapasin-ERp57 thiol oxidoreductase heterodimer. Immunity 30(1):21–32. doi: 10.1016/j.immuni.2008.10.018 CrossRefPubMedCentralPubMedGoogle Scholar
  7. Elliott T, Williams A (2005) The optimization of peptide cargo bound to MHC class I molecules by the peptide-loading complex. Immunol Rev 207:89–99. doi: 10.1111/j.0105-2896.2005.00311.x CrossRefPubMedGoogle Scholar
  8. Fruci D, Ferracuti S, Limongi MZ, Cunsolo V, Giorda E, Fraioli R, Sibilio L, Carroll O, Hattori A, van Endert PM, Giacomini P (2006) Expression of endoplasmic reticulum aminopeptidases in EBV-B cell lines from healthy donors and in leukemia/lymphoma, carcinoma, and melanoma cell lines. J Immunol 176(8):4869–4879CrossRefPubMedGoogle Scholar
  9. Garbi N, Tan P, Diehl AD, Chambers BJ, Ljunggren HG, Momburg F, Hammerling GJ (2000) Impaired immune responses and altered peptide repertoire in tapasin-deficient mice. Nat Immunol 1(3):234–238. doi: 10.1038/79775 CrossRefPubMedGoogle Scholar
  10. Garbi N, Tanaka S, Momburg F, Hammerling GJ (2006) Impaired assembly of the major histocompatibility complex class I peptide-loading complex in mice deficient in the oxidoreductase ERp57. Nat Immunol 7(1):93–102. doi: 10.1038/ni1288 CrossRefPubMedGoogle Scholar
  11. Grandea AG 3rd, Golovina TN, Hamilton SE, Sriram V, Spies T, Brutkiewicz RR, Harty JT, Eisenlohr LC, Van Kaer L (2000) Impaired assembly yet normal trafficking of MHC class I molecules in tapasin mutant mice. Immunity 13(2):213–222Google Scholar
  12. Hammer GE, Gonzalez F, Champsaur M, Cado D, Shastri N (2006) The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules. Nat Immunol 7(1):103–112. doi: 10.1038/ni1286 CrossRefPubMedGoogle Scholar
  13. Hammer GE, Gonzalez F, James E, Nolla H, Shastri N (2007a) In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides. Nat Immunol 8(1):101–108. doi: 10.1038/ni1409 CrossRefPubMedGoogle Scholar
  14. Hammer GE, Kanaseki T, Shastri N (2007b) The final touches make perfect the peptide-MHC class I repertoire. Immunity 26(4):397–406. doi: 10.1016/j.immuni.2007.04.003 CrossRefPubMedGoogle Scholar
  15. Jiang Q, Pan HY, Ye DX, Zhang P, Zhong LP, Zhang ZY (2010) Downregulation of tapasin expression in primary human oral squamous cell carcinoma: association with clinical outcome. Tumour Biol 31(5):451–459. doi: 10.1007/s13277-010-0054-4 CrossRefPubMedGoogle Scholar
  16. Kanaseki T, Blanchard N, Hammer GE, Gonzalez F, Shastri N (2006) ERAAP synergizes with MHC class I molecules to make the final cut in the antigenic peptide precursors in the endoplasmic reticulum. Immunity 25(5):795–806. doi:10.1016/j.immuni.2006.09.012Google Scholar
  17. Kanaseki T, Camfield Lind K, Escobar H, Nagarajan N, Reyes-Vargas E, Rudd B, Rockwood AL, Van Kaer L, Sato N, Delgado JC, Shastri N (2013) ERAAP and tapasin independently edit the amino and carboxyl termini of MHC class I peptides. J Immunol 191(4):1547–1555Google Scholar
  18. Kessler JH, Khan S, Seifert U, Le Gall S, Chow KM, Paschen A, Bres-Vloemans SA, de Ru A, van Montfoort N, Franken KL, Benckhuijsen WE, Brooks JM, van Hall T, Ray K, Mulder A, Doxiadis II, van Swieten PF, Overkleeft HS, Prat A, Tomkinson B, Neefjes J, Kloetzel PM, Rodgers DW, Hersh LB, Drijfhout JW, van Veelen PA, Ossendorp F, Melief CJ (2011) Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes. Nat Immunol 12(1):45–53. doi: 10.1038/ni.1974 CrossRefPubMedGoogle Scholar
  19. Kim S, Lee S, Shin J, Kim Y, Evnouchidou I, Kim D, Kim YK, Kim YE, Ahn JH, Riddell SR, Stratikos E, Kim VN, Ahn K (2011) Human cytomegalovirus microRNA miR-US4-1 inhibits CD8(+) T cell responses by targeting the aminopeptidase ERAP1. Nat Immunol 12(10):984–991. doi: 10.1038/ni.2097 CrossRefPubMedCentralPubMedGoogle Scholar
  20. Kincaid EZ, Che JW, York I, Escobar H, Reyes-Vargas E, Delgado JC, Welsh RM, Karow ML, Murphy AJ, Valenzuela DM, Yancopoulos GD, Rock KL (2011) Mice completely lacking immunoproteasomes show major changes in antigen presentation. Nat Immunol 13(2):129–135. doi: 10.1038/ni.2203 CrossRefPubMedCentralPubMedGoogle Scholar
  21. Kunisawa J, Shastri N (2003) The group II chaperonin TRiC protects proteolytic intermediates from degradation in the MHC class I antigen processing pathway. Mol Cell 12(3):565–576. doi: 10.1016/j.molcel.2003.08.009
  22. Lewis JW, Elliott T (1998) Evidence for successive peptide binding and quality control stages during MHC class I assembly. Curr Biol 8(12):717–720CrossRefPubMedGoogle Scholar
  23. Lilley BN, Ploegh HL (2005) Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond. Immunol Rev 207:126–144. doi: 10.1111/j.0105-2896.2005.00318.x
  24. Lou Y, Vitalis TZ, Basha G, Cai B, Chen SS, Choi KB, Jeffries AP, Elliott WM, Atkins D, Seliger B, Jefferies WA (2005) Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumor-specific immune responses and survival. Cancer Res 65(17):7926–7933PubMedGoogle Scholar
  25. Lybarger L, Wang X, Harris M, Hansen TH (2005) Viral immune evasion molecules attack the ER peptide-loading complex and exploit ER-associated degradation pathways. Curr Opin Immunol 17(1):71–78. doi: 10.1016/j.coi.2004.11.009 CrossRefPubMedGoogle Scholar
  26. Nagarajan NA, Gonzalez F, Shastri N (2012) Nonclassical MHC class Ib-restricted cytotoxic T cells monitor antigen processing in the endoplasmic reticulum. Nat Immunol.  doi:10.1038/ni.2282 PubMedCentralPubMedGoogle Scholar
  27. Ogino T, Shigyo H, Ishii H, Katayama A, Miyokawa N, Harabuchi Y, Ferrone S (2006) HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker. Cancer Res 66(18):9281–9289. doi: 10.1158/0008-5472.CAN-06-0488 CrossRefPubMedGoogle Scholar
  28. Oliveira CC, van Veelen PA, Querido B, de Ru A, Sluijter M, Laban S, Drijfhout JW, van der Burg SH, Offringa R, van Hall T (2010) The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects. J Exp Med 207(1):207–221. doi: 10.1084/jem.20091429 CrossRefPubMedCentralPubMedGoogle Scholar
  29. Ortmann B, Copeman J, Lehner PJ, Sadasivan B, Herberg JA, Grandea AG, Riddell SR, Tampe R, Spies T, Trowsdale J, Cresswell P (1997) A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. Science 277(5330):1306–1309CrossRefPubMedGoogle Scholar
  30. Pamer E, Cresswell P (1998) Mechanisms of MHC class I–restricted antigen processing. Annu Rev Immunol 16:323–358. doi: 10.1146/annurev.immunol.16.1.323 CrossRefPubMedGoogle Scholar
  31. Park B, Kim Y, Shin J, Lee S, Cho K, Fruh K, Ahn K (2004) Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. Immunity 20(1):71–85CrossRefPubMedGoogle Scholar
  32. Rammensee HG, Falk K, Rotzschke O (1993) Peptides naturally presented by MHC class I molecules. Annu Rev Immunol 11:213–244. doi: 10.1146/annurev.iy.11.040193.001241 CrossRefPubMedGoogle Scholar
  33. Reits E, Neijssen J, Herberts C, Benckhuijsen W, Janssen L, Drijfhout JW, Neefjes J (2004) A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation. Immunity 20(4):495–506CrossRefPubMedGoogle Scholar
  34. Rock KL, Goldberg AL (1999) Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu Rev Immunol 17:739–779. doi: 10.1146/annurev.immunol.17.1.739 CrossRefPubMedGoogle Scholar
  35. Saric T, Chang SC, Hattori A, York IA, Markant S, Rock KL, Tsujimoto M, Goldberg AL (2002) An IFN-gamma-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nat Immunol 3(12):1169–1176. doi: 10.1038/ni859 CrossRefPubMedGoogle Scholar
  36. Serwold T, Gonzalez F, Kim J, Jacob R, Shastri N (2002) ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 419(6906):480–483. doi: 10.1038/nature01074 CrossRefPubMedGoogle Scholar
  37. Shastri N, Schwab S, Serwold T (2002) Producing nature’s gene-chips: the generation of peptides for display by MHC class I molecules. Annu Rev Immunol 20:463–493. doi: 10.1146/annurev.immunol.20.100301.064819 CrossRefPubMedGoogle Scholar
  38. Shen XZ, Billet S, Lin C, Okwan-Duodu D, Chen X, Lukacher AE, Bernstein KE (2011) The carboxypeptidase ACE shapes the MHC class I peptide repertoire. Nat Immunol 12(11):1078–1085. doi: 10.1038/ni.2107 CrossRefPubMedCentralPubMedGoogle Scholar
  39. Tan P, Kropshofer H, Mandelboim O, Bulbuc N, Hammerling GJ, Momburg F (2002) Recruitment of MHC class I molecules by tapasin into the transporter associated with antigen processing-associated complex is essential for optimal peptide loading. J Immunol 168(4):1950–1960CrossRefPubMedGoogle Scholar
  40. Tynan FE, Burrows SR, Buckle AM, Clements CS, Borg NA, Miles JJ, Beddoe T, Whisstock JC, Wilce MC, Silins SL, Burrows JM, Kjer-Nielsen L, Kostenko L, Purcell AW, McCluskey J, Rossjohn J (2005) T cell receptor recognition of a ‘super-bulged’ major histocompatibility complex class I-bound peptide. Nat Immunol 6(11):1114–1122. doi: 10.1038/ni1257 CrossRefPubMedGoogle Scholar
  41. van Hall T, Wolpert EZ, van Veelen P, Laban S, van der Veer M, Roseboom M, Bres S, Grufman P, de Ru A, Meiring H, de Jong A, Franken K, Teixeira A, Valentijn R, Drijfhout JW, Koning F, Camps M, Ossendorp F, Karre K, Ljunggren HG, Melief CJ, Offringa R (2006) Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants. Nat Med 12(4):417–424. doi: 10.1038/nm1381 CrossRefPubMedGoogle Scholar
  42. Van Kaer L, Ashton-Rickardt PG, Ploegh HL, Tonegawa S (1992) TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells. Cell 71(7):1205–1214CrossRefPubMedGoogle Scholar
  43. Vance RE, Kraft JR, Altman JD, Jensen PE, Raulet DH (1998) Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J Exp Med 188(10):1841–1848CrossRefPubMedCentralPubMedGoogle Scholar
  44. Wearsch PA, Cresswell P (2007) Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer. Nat Immunol 8(8):873–881. doi: 10.1038/ni1485 CrossRefPubMedGoogle Scholar
  45. York IA, Chang SC, Saric T, Keys JA, Favreau JM, Goldberg AL, Rock KL (2002) The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8–9 residues. Nat Immunol 3(12):1177–1184. doi: 10.1038/ni860 CrossRefPubMedGoogle Scholar
  46. York IA, Bhutani N, Zendzian S, Goldberg AL, Rock KL (2006) Tripeptidyl peptidase II is the major peptidase needed to trim long antigenic precursors, but is not required for most MHC class I antigen presentation. J Immunol 177(3):1434–1443CrossRefPubMedGoogle Scholar

Copyright information

© Springer Japan 2015

Authors and Affiliations

  • Takayuki Kanaseki
    • 1
    Email author
  • Yosuke Shionoya
    • 1
  • Noriyuki Sato
    • 2
  1. 1.Department of PathologySapporo Medical University School of MedicineSapporoJapan
  2. 2.School of MedicineSapporo Medical UniversitySapporoJapan

Personalised recommendations